Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis [PDF]
, 2015 Supported by the Global Alliance for TB Drug Development with support from the Bill and Melinda Gates Foundation, the European and Developing Countries Clinical Trials Partnership, U.S. Agency for International Development, U.K.
Crook, Angela M. +9 more
core +1 more source
The Effect of Ethambutol on Optic Nerve by Spectral Domain Optical Coherence Tomography
Namık Kemal Tıp Dergisi, 2020 Aim:To evaluate; the retinal nerve fiber layer difference between healthy control groups and patients who were taking ethambutol medication by using spectral domain optical coherence tomography (SD-OCT) and to evaluate the usage of SD-OCT for early ...
Gül VARAN, Ahmet ŞAHİN
doaj +1 more source
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report [PDF]
, 2018 Rationale: Tuberculous meningitis is a highly morbid, often fatal disease. Patient concern: We describe a case of an Italian child. Diagnoses: we diagnosed early a Tuberculous meningitis complicated by the occurrence of hydrocephalus, stroke, and ...
Ajassa, Camilla +8 more
core +1 more source
Infection and Drug Resistance, 2021 Aiketaguli Anwaierjiang,1,* Quan Wang,2,* Haican Liu,3,* Chunjie Yin,1 Miao Xu,2 Machao Li,3 Mengwen Liu,1 Yan Liu,2 Xiuqin Zhao,3 Jinbao Liu,1 Guilian Li,3 Xiaokaiti Mijiti,2 Kanglin Wan3 1College of Public Health, Xinjiang Medical ...
Anwaierjiang A +12 more
doaj
International Journal of Mycobacteriology, 2020 Tuberculosis (TB) is an infection that can affect any organ, affecting mainly the lungs. Isolated testicular TB is very rare. Six months of a multiple drug scheme is the mainstay of TB treatment.
Flávio Godinho Pereira +3 more
doaj +1 more source
Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line [PDF]
Genetics and Molecular Biology, 2023 Genetically antimicrobial resistance in Mycobacterium tuberculosis is currently one of the most important aspects of tuberculosis, considering that there are emerging resistant strains for almost every known drug used for its treatment.
Nicolas de Oliveira Rossini +1 more
doaj +1 more source
Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide
Molecules, 2017 Tuberculosis (TB) is a bacterial disease responsible for millions of infections and preventable deaths each year. Its treatment is complicated by patients’ noncompliance due to dosing frequency, lengthy treatment, and adverse side effects associated with
Bullo Saifullah +6 more
doaj +1 more source
Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis. [PDF]
, 2016 BackgroundTuberculosis (TB) is the leading cause of death from an infectious pathogen worldwide and the most prevalent opportunistic infection in people living with HIV.
Bacchetti, Peter +6 more
core +1 more source
Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions [PDF]
, 2014 Antimicrobials targeting cell wall biosynthesis are generally considered inactive against nonreplicating bacteria. Paradoxically, we found that under nonpermissive growth conditions, exposure of Mycobacterium bovis BCG bacilli to such antimicrobials ...
Andrew, Peter W +12 more
core +2 more sources
Treatment of tuberculosis in a region with high drug resistance: Outcomes, drug resistance amplification and re-infection [PDF]
, 2011 Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. Methods: We combined drug susceptibility results and molecular strain typing data with treatment outcome ...
Andrew, P W +16 more
core +2 more sources